Navigation Links
Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
Date:2/4/2008

ivately-owned company is developing six clinical-stage compounds acquired through key partnerships with Novartis, Roche and Syngenta. Synosia's pipeline includes two marketed drugs that will be tested in new indications, extending their reach into new neurological and psychiatric diseases with high unmet medical need, including anxiety and Parkinson's Disease. Synosia's corporate headquarters is in Basel, Switzerland.

Disclaimer

This communication expressly or implicitly contains certain forward-looking statements concerning Synosia Therapeutics and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Synosia Therapeutics to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Synosia Therapeutics is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Contact:

Synosia Therapeutics

In Europe:

Julie Walters at Tudor Reilly

Tel: +44(0)20-7016-7714

Mobile +44(0)775-3626967

julie.walters@tudor-reilly.com

In US:

Michele Parisi at Tudor Reilly

Tel: +1-925-864-5028

michele.parisi@tudor-reilly.com


'/>"/>
SOURCE Synosia Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
2. Synosia Therapeutics Announces Appointment of Chief Business Officer
3. Taligen Therapeutics Secures Series B Financing
4. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
5. CV Therapeutics to Host Investor Science Day on Thursday, February 7, 2008
6. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
7. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
8. CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008
9. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
10. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
11. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...ire/ -- The Eniva Research Group has,released resu...us Pauling,Micronutrient Research Institute at Ore...Health Supplement VIBE(R) possessed DNA protective...rd party testing was,performed as part of an ongoi...isms by which the Eniva VIBE nutraceutical impacts...
(Date:7/3/2008)...e/ - OncoGenex Technologies Inc. and Isis,Pharmace...t the companies,have amended their agreement and O...lead cancer drug OGX-011. Under the amended agreem...e development activities,costs and partnering dec...responsible for funding 35% of development costs, ...
(Date:7/3/2008)...wswire-FirstCall/ -- AMDL, Inc. (Amex:,ADL), a wor...ed in Tustin,Ca., with operations in Shenzhen, Ji...leased its investor presentation which is availabl...www.amdl.com ., About AMDL:, AMDL, Inc. is a glo...is,headquartered in Tustin, California with operat...
(Date:7/2/2008)... Stent to Demonstrate Superiority Over,Market-Lead...ted States for Treatment of Coron...Newswire-FirstCall/ -- Abbott today,announced that...ved the,XIENCE(TM) V Everolimus Eluting Coronary S...isease. XIENCE V is the only drug eluting stent to...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...s. - Two of the largest U.S.-based multi-national...Milwaukee County Research Park . , , Johnson Contr...the park, according to Dave Domres, vice president...ers, LLC . , ,Johnson Controls, a Milwaukee-based...lobal manufacturer of automotive systems, plans to...
...es with Google , Yahoo , and MSN have marketer..., ,In recent months, popular search engines have u...ers to target specific ad positions within search ...results; and Yahoo announced a partnership with eB...ting search engines remains uncertain, it,s certai...
...article, we looked at the leading pharmaceutical c...cal market, which for the first time surpassed $6...rt of equation, as another significant market is t...e numbers on the size of the total medical device ... $200 billion in annual revenue in 2005, as the to...
... - Since its inception, Venture Investors has e...at was popularized on the coasts, and it now has a...arly-stage businesses. , ,The Madison-based ventur... from mostly Wisconsin sources for its new Venture... and already is in discussions with several prospe...
Other Biology Technology:Location, location, location: Spots to consider for online ads 2Location, location, location: Spots to consider for online ads 3Location, location, location: Spots to consider for online ads 4Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7Venture Investors looks to fund 20 companies 2Venture Investors looks to fund 20 companies 3
(Date:7/2/2008)... to produce a lot of a substance -- such as a newl...olecules that speed chemical reactions. Many jobs ...one in just the right shape to connect with certai...uch as enzymes in the human body that help us dige... to suit the task at hand. , Chemists have made ...
(Date:7/2/2008)...n . , Metabolomics aims to determine the totalit...e exponents of bioinformatics analyzed data collec...s study in healthy and diabetic mice. In each case...iabetes drug RoziglitazoneTM. Then, more than 800 ...ood plasma sample of a total of forty mice, repres...
(Date:7/2/2008)...ish . , Most of the functions performed by a ce..., which recognise their binding partner by affinit... are many kinds of interactions; however, the most...ctural biology are those which are transient. This... large section of the protein surface- the globula...
(Date:7/2/2008)...its kind, using sophisticated methods to measure b...eight loss program, Weight Watchers, was compared ...d wins in the game of good health. A University of...ences of participants to determine which program h...health benefits. The answer is that both have pros...
Breaking Biology News(10 mins):Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Weight Watchers vs. fitness centers 2Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 3414 1Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 3414 2Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 1Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 2Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 3Understanding autumn rain decline in SE Australia 3411 1Understanding autumn rain decline in SE Australia 3411 2TriWest Teaches California Kids About Veterans Sacrifice Courage 20159 1TriWest Teaches California Kids About Veterans Sacrifice Courage 20159 2
...particles weaken the bonding of hip, knee, and oth...shed online in Proceedings of the National Academy...alifornia, San Diego (UCSD) School of Medicine and...trated that titanium implants are safe in large bl...can generate micrometer-sized particles. , "As re...
...overed a fascinating symbiotic relationship betwee...species ?a relationship that potentially sheds lig... higher organisms in defensive mechanisms against ...that a solitary ground-nesting wasp, the European ...tructures within its antennae and that females uti...
...t imaging technology a team from Yale School of Me...nt ,nano-machines, in action. The work, performed ...s, provides new insight into the machinery cells u...lls traffic protein cargos across their outer memb...go internalization is clathrin mediated endocytosi...
...lished in the Journal of Biological Chemistry, sci...to play a purely structural and inert role in cell...cancer. Using antagonists for this molecule, the r...reast cancer cells to chemotherapeutic drug treatm...Week" in the May 27 issue of the Journal of Biolog...
Other Biology News:UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints 2Symbiotic bacteria protect hunting wasps from fungal infestation 2Researchers develop assay that could be applied to drug screening 2New polysaccharide may help combat multidrug resistance in cancer 2
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications).
PhosphoSafe Extraction Reagent extracts cytosolic proteins from mammalian and insect cells while preserving their phosphorylation state. The reagent, an enhancement of the CytoBuster Protein Extracti
Yersinia pestis
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications).
Biology Products: